MYND ANALYTICS, INC. (OTCMKTS:MYAN) Files An 8-K Financial Statements and ExhibitsItem 9.01
99.1 Investor Presentation (July 2017)
MYnd Analytics, Inc. ExhibitEX-99.1 2 s106971_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 PREDICTIVE MEDICINE FOR MENTAL HEALTH July2017 Investor Presentation NASDAQ: MYND Investor Presentation DISCLAIMER This presentation contains “forward – looking statements” pursuant to the safe – harbor provisions of the Private Securities Litigation Reform Act of 1995 that include information relating to future events,…To view the full exhibit click here
About MYND ANALYTICS, INC. (OTCMKTS:MYAN)
MYnd Analytics, Inc., formerly CNS Response, Inc., is a cloud-based predictive analytics company that provides objective clinical decision support to mental healthcare providers for the treatment of behavioral disorders, including depression, anxiety, bipolar disorder and post-traumatic stress disorder (PTSD). It uses its neurometric platform, PEER Online, to generate Psychiatric Electroencephalogram, Evaluation Registry Reports to predict the likelihood of response by an individual to certain medications for the treatment of behavioral disorders. The Company’s technology helps in evaluating pharmacotherapy options in patients suffering from non-psychotic behavioral disorders. PEER provides medical professionals with medication sensitivity data for a subject patient based upon the identification and correlation of treatment outcome information from other patients with similar neurophysiologic characteristics. This treatment outcome information is contained in the PEER Online database.